These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1989162)

  • 1. Cellular infiltrates during different immunosuppressive regimens in renal transplantation.
    Egidi F; Stucchi L; Cantù MA; Ponticelli C
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1115-6. PubMed ID: 1989162
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinicopathological analysis of rejection episodes in ABO-incompatible kidney transplantation.
    Tanabe K; Takahashi K; Sonda K; Onituka S; Yamaguchi Y; Agishi T; Koga S; Koga T; Nakazawa H; Goya N; Yagisawa T; Fuchinoue S; Kawai T; Toma H; Ota K
    Transplant Proc; 1996 Jun; 28(3):1447-8. PubMed ID: 8658734
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of macrophage subsets in renal allograft biopsies with new monoclonal antibodies.
    Burkhardt K; Sorg C; Andreesen R; Mues B; Hammer C; Land W; Gurland HJ
    Transplant Proc; 1990 Aug; 22(4):1844-5. PubMed ID: 2389457
    [No Abstract]   [Full Text] [Related]  

  • 4. Fine needle aspiration biopsy of human renal transplants.
    Nishioka T; Negita M; Ikegami M; Imanishi M; Ishii T; Uemura T; Kunikata S; Kanda H; Matsuura T; Akiyama T
    Transplant Proc; 1992 Aug; 24(4):1551-3. PubMed ID: 1496655
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine monotherapy in children: long-term effect.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2610-6. PubMed ID: 7940813
    [No Abstract]   [Full Text] [Related]  

  • 6. A comparative study of clinicopathologic characteristics of renal allografts under cyclosporine and FK506 immunosuppression.
    Sugito K; Morozumi K; Oikawa T
    Transplant Proc; 1996 Jun; 28(3):1335-7. PubMed ID: 8658683
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunopharmacologic therapy in renal transplantation.
    Shoker AS
    Pharmacotherapy; 1996; 16(4):562-75. PubMed ID: 8840362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of cyclosporine monotherapy--long-term graft function.
    Birkeland SA; Elbirk A; Rohr N; Jørgensen KA
    Transplant Proc; 1994 Oct; 26(5):2501-6. PubMed ID: 7940767
    [No Abstract]   [Full Text] [Related]  

  • 9. Protocol biopsies in stable renal transplant patients under triple immunosuppression: results at 6 months.
    Rush DN; Jeffery JR; Gough J
    Transplant Proc; 1994 Oct; 26(5):2576. PubMed ID: 7940797
    [No Abstract]   [Full Text] [Related]  

  • 10. MRP8/14-positive macrophages as early acute cellular rejection markers, and soluble MRP8/14 and increased expression of adhesion molecules following renal transplantation.
    Burkhardt K; Bösnecker A; Hillebrand G; Hofmann GO; Schneeberger H; Burmeister G; Land W; Gurland HJ
    Transplant Proc; 1995 Feb; 27(1):890-1. PubMed ID: 7533437
    [No Abstract]   [Full Text] [Related]  

  • 11. Managing the failing allograft.
    Kendrick EA; Davis CL
    Semin Dial; 2005; 18(6):529-39. PubMed ID: 16398717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misoprostol in renal transplantation.
    Curtis LD; Anwar N; Briggs JD; Buckels JA; Jones M; Karim MS; Koffman G; McGregor E; Neild G; Riad HN
    Transplant Proc; 1993 Feb; 25(1 Pt 1):602. PubMed ID: 8438432
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary dysfunction of renal allografts as a risk factor.
    Margreiter R; Bösmüller C; Spielberger M; Königsrainer A; Dünser M
    Transplant Proc; 1990 Aug; 22(4):1373-4. PubMed ID: 2389333
    [No Abstract]   [Full Text] [Related]  

  • 14. Interleukin-2 stimulation of tumor necrosis factor synthesis by peripheral blood mononuclear cells in renal allograft rejection.
    Meulders Q; Rondeau E; Delarue F; Lacave R; Sraer JD
    Transplant Proc; 1990 Aug; 22(4):1987-8. PubMed ID: 2389504
    [No Abstract]   [Full Text] [Related]  

  • 15. Dense B cell infiltrates in paediatric renal transplant biopsies are predictive of allograft loss.
    Muorah MR; Brogan PA; Sebire NJ; Trompeter RS; Marks SD
    Pediatr Transplant; 2009 Mar; 13(2):217-22. PubMed ID: 18433412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-based triple immunosupression with antithymocyte globulin induction in expanded criteria donor kidney transplantation.
    Uslu A; Nart A; Taşli FA; Postaci H; Aykas A; Doğan M; Sahin T
    Nephrology (Carlton); 2008 Feb; 13(1):80-6. PubMed ID: 18199109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of the postrejection treatment biopsy in renal transplantation.
    Mozes MF; Manaligod JR; Duke D; Pollak R; Maddux M; Jonasson O
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1625-6. PubMed ID: 3274391
    [No Abstract]   [Full Text] [Related]  

  • 18. Update in immunosuppression.
    Huizinga R
    Nephrol Nurs J; 2002 Jun; 29(3):261-7. PubMed ID: 12164076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. OKT3 for steroid-resistant renal allograft rejection: differential response in adults and children.
    Shmueli D; Nakache R; Lustig S; Bar Nathan N; Yussim A; Shaharabani E; Geier A; Shapira Z
    Transplant Proc; 1994 Aug; 26(4):1948-9. PubMed ID: 8066630
    [No Abstract]   [Full Text] [Related]  

  • 20. Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy.
    Ciancio G; Carreno M; Mathew J; Ricordi C; Garcia R; Karatzas T; Fuller L; Cirocco R; Burke G; Webb M; Nery J; Tzakis A; Roth D; Esquenazi V; Miller J
    Transplant Proc; 1996 Apr; 28(2):943-4. PubMed ID: 8623473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.